Charles Kolodkin | September 29, 2001
Premiums are doubling, deductibles tripling, and insurers are abandoning the line. Charles Kolodkin explains why the condition of the market is quite rationale and not surprising.
A quick examination of the medical malpractice insurance marketplace in the second half of 2001 might lead a dispassionate observer to conclude this segment of the insurance industry is confused, in disarray, and generally in a state of disorder. Premiums are doubling, hospital deductibles are tripling, claims-free physicians are being nonrenewed, insurers are leaving territories en masse. Simply put, the market is in chaos.
Ask an insurance agent or broker specializing in medical malpractice coverage and you will no doubt receive confirmation of this turmoil. Survey a physician or hospital risk manager on this subject, especially one that has recently sought professional liability insurance protection, and you will likely hear a litany of complaints suggesting disgust, bewilderment, and helplessness. The reaction from insurers themselves may come with a wry smile, but they too will agree the market is in a chaotic state. Yet, in a perverse way, the condition of the medical malpractice market is actually quite rationale and not at all surprising.
What is happening to the market for medical malpractice insurance in 2001 is a direct result of trends and events present since the mid to late 1990s. Throughout the 1990s and reaching a peak around 1997 and 1998, insurers were on a quest for market share, that is, they were driven more by the amount of premium they could book rather than the adequacy of premiums to pay losses. In large part this emphasis on market share was driven by a desire to accumulate large amounts of capital with which to turn into investment income.
In a perfect world, investment income would cover any deficiencies that might exist in underwriting results and the insurers' aggressive marketing and pricing strategy would prove to be successful. Alas, we do not live in a perfect insurance world and, as competition intensified, underwriting results deteriorated. Regardless of the level of risk management intervention, proactive claims management, or tort reform, the fact remains that if insurance policies are consistently underpriced, the insurer will lose money.
The following table displays the performance of insurers issuing medical malpractice coverage in the United States during the decade of the 1990s.
Year | Net Premiums Written | Combined Ratio* |
---|---|---|
1990 | $4,014,622,000 | 101.9% |
1991 | $4,067,803,000 | 99.0% |
1992 | $4,133,567,000 | 123.4% |
1993 | $4,370,812,000 | 104.5% |
1994 | $4,780,537,000 | 94.2% |
1995 | $4,800,552,000 | 96.4% |
1996 | $4,875,486,000 | 102.6% |
1997 | $4,892,496,000 | 103.5% |
1998 | $5,145,066,000 | 111.9% |
1999 | $5,104,147,000 | 125.8% |
Source: A.M. Best Co. |
It only takes a quick view of insurance companies' results during the past few years to realize how poorly the sector has performed. As bad a year as 1998 was, evidenced by a combined ratio of 112 percent, 1999 results are worse, weakening to 126 percent. Preliminary information indicates the trend deteriorating in 2000 to 140 percent. In other words, for every $1.00 medical malpractice insurers were receiving in 2000 as premium, they will pay out $1.40 in losses and expenses.
Clearly a business cannot continue operating in this fashion indefinitely. Indeed, this has been the case for such long time writers of professional liability insurance as Frontier, Reliance, and P.I.E Mutual. These companies, who suffered through several years of weakening performance, have been liquidated or are otherwise inactive.
In August 2001, the list of impaired medical malpractice insurers got longer as the Pennsylvania Department of Insurance placed PHICO under state rehabilitation. PHICO, one of the ten largest writers of medical malpractice insurance, has been one of the more aggressive underwriters during the late 1990s. The company has seen its surplus decrease dramatically over the past year and half from almost $200 million to under $10 million. Regulatory intervention was necessary as it became obvious PHICO's premiums had been inadequate to cover losses.
In light of these dismal results, the insurance industry realizes it must take action. A top executive of St. Paul Insurance Company, the country's largest writer of medical malpractice insurance, recently stated, healthcare liability "is the most dramatically underperforming segment of the marketplace." In response, the Minnesota based insurer is reevaluating its marketing strategy, examining not only its premium rating structure, but also the territories, product lines, and coverage limits it will offer.
St. Paul is hardly unique. It is safe to say every insurance company actively insuring hospitals and physicians has gone through an intensive introspection of its marketing strategy during the past 12 months.
Insurance companies are evaluating all aspects of underwriting, and not just premiums. As of 2001, the effects of this introspection by the medical malpractice insurance community remain unclear, although one thing is certain: the aggressiveness of the 1990s characterized by soft pricing is over. Insurers are now examining the territories they will write, the medical specialties to be targeted, the amount of coverage to make available, deductibles required, and the way they make underwriting decisions.
The following are examples of the way medical malpractice underwriting is changing.
The immediate prospects for the buyer of hospital professional liability insurance or physician malpractice coverage are not promising. Rates likely will continue to increase, market capacity will further shrink, and insurers will be highly selective about the risks they will write.
Although premium rates started their climb in 2000 and noticeably increased in 2001, most underwriters feel they are still insufficient to cover losses. Indications for 2002 are more rate increases. St. Paul raised rates for large hospitals it has renewed thus far in 2001 by an average of 76 percent. The company's price increases have been even steeper in recent months, with renewal increases in July 2001 up 103 percent from last year. This is not an isolated phenomenon.
During the soft market a prospective insured really was not closely scrutinized when it applied for coverage. This was the case for both institutions as well as physicians. In the quest for market share, insurers would issue a quote in days, if not hours. The information requests of underwriters were hardly exhaustive.
The tide has turned. All insurers insist on a detailed, completed application from the insured with a comprehensive summary of operations. For many hospitals, the insurance company will not prepare a quote without first performing a site visit. In today's world, underwriters require thorough loss information, including a current loss run identifying an insured's open and closed claims. In the event any of these materials are not submitted, it is doubtful an underwriter will release a quotation.
In view of the woeful operating results in the medical malpractice insurance segment, an influx of new insurers is unlikely in 2002. Most potential risk bearers will await the outcome of the changes that have occurred in 2001, such as higher rates and focused underwriting, before committing capital and resources to the industry. It is important to realize the impact of these changes may take a number of years to be fully understood, particularly since medical malpractice claims are among the slowest in the industry to develop. Thus, additional capacity in the form of new insurance companies entering the medical malpractice environment appears far off.
One source of possible relief for hospitals and physician groups may be in the reemergence of alternative risk funding vehicles, for example, captive insurance companies, both group and single-parent sponsored; rent-a-captives; risk purchasing pools; risk retention groups; and insurance reciprocals. These structures, popular in both the late 1970s and again in the mid-1980s, lost much of their allure as insurance companies slashed premiums. But with the return of hard market conditions, buyers will seek options outside of the commercial marketplace. These alternative risk funding vehicles promising pricing stability and more control for the insured should again prove increasingly attractive.
To an experienced and keen insurance professional, the dreadful operating results medical malpractice insurers are now suffering are scarcely surprising and are a direct outcome of an inadequately priced product. Although a hardening of the market with significant premium increases has long been anticipated, the extent of the change has surprised many. Insurers have been forced to not only reevaluate their pricing, but their entire business strategy. While this process continues, the medical malpractice insurance industry will remain in upheaval—a state of chaos.
Author's note: Due to the timeliness of the subject matter, several writers and groups have used quotations from this article. Although it is flattering when your work is cited as a reference, it is important that proper context be maintained. The chaos in the medical malpractice insurance marketplace has been created by a historically underpriced product. Premiums, along with investment income, have been inadequate to cover the claims costs and expenses insurance companies have incurred.
Opinions expressed in Expert Commentary articles are those of the author and are not necessarily held by the author's employer or IRMI. Expert Commentary articles and other IRMI Online content do not purport to provide legal, accounting, or other professional advice or opinion. If such advice is needed, consult with your attorney, accountant, or other qualified adviser.